InMode (INMD) Stock Highlights

17.37 | +1.82%

2024-09-18 03:07:50

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and womens health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its products platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, Evolve, Evoke, and Morpheus8. The majority of its revenue comes from the United States.

Statistics

Range Today

17.07 17.8

Volume Today 800.4K

Range 1 Year

15.39 34.43

Volume 1 Year 403.47M

Range 3 Year

15.39 99.27

Volume 3 Year 1.25B

Range 10 Year

13.06 140.9

Volume 10 Year 1.77B

Highlights

Market Capitalization 1.3B (small)

Floating Shares 75.7M

Current Price 17.37

Price To Earnings 9.83

Price To Revenue 1.7

Price To Book 1.9

Earnings Per Share 1.73

Payout Ratio 0%

Performance

Latest +1.82%

1 Month +8.09%

3 Months -4.61%

6 Months -17.56%

1 Year -48.87%

3 Years -76.04%

5 Years -37.18%

10 Years +27.49%

Benchmarks

Market Capitalization

28 / 92

Gross Profits

23 / 85

Total Revenue

27 / 89

Total Rank

24 / 92

Free Cashflow

12 / 90

Performance 5 years

52 / 92

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.